Royal Bank of Canada
MYGN icon

Royal Bank of Canada’s Myriad Genetics MYGN Stock Holding History

Royal Bank of Canada’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-49,800
Closed -$713K – 6802
2020
Q1 		$713K Sell
49,800
-50,200
-50% -$1.06M ﹤0.01% 3304
2019
Q4 		$2.72M Buy
+100,000
New +$2.75M ﹤0.01% 2614
2014
Q4 		– Sell
-100
Closed -$4K – 6256
2014
Q3 		$4K Buy
+100
New +$3.73K ﹤0.01% 5688
2014
Q2 		– Sell
-95,400
Closed -$3.26M – 6066
2014
Q1 		$3.26M Buy
+95,400
New +$2.96M ﹤0.01% 1899

Other funds holding MYGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada's MYGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Myriad Genetics (MYGN) stake by 89% in Q1 2026, selling an estimated $23.1K and leaving 564 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6727.

Royal Bank of Canada first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.16M in Q3 2018. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Royal Bank of Canada held 564 shares of Myriad Genetics worth $2K as of Q1 2026.
  • Royal Bank of Canada sold 4,429 Myriad Genetics shares in Q1 2026, an estimated $23.1K.
  • Myriad Genetics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6727 holding.
  • Royal Bank of Canada first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Myriad Genetics position peaked at $8.16M in Q3 2018.
  • 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.